HLA-DR antigens associated with major genetic risk for late-onset Alzheimerʼs disease
- 1 April 1997
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (6), 1467-1469
- https://doi.org/10.1097/00001756-199704140-00028
Abstract
Hla-dr antigen types were determined from DNA isolated from post-mortem brain tissue of age-matched groups of 78 patients with pathologically confirmed late-onset Alzheimer's disease (AD) and 50 controls. The results suggest that for individuals with no apolipoprotein E epsilon 4 alleles the presence of either DR1, 2 or 3 antigens is associated with a significantly increased risk for development of late-onset AD. Conversely the DR4 or 6 antigens are associated with a decreased risk of similar magnitude. This DR effect, rather than prolonged use of non-steroidal anti-inflammatory drugs, could be responsible for the reported lower prevalence of AD in rheumatoid arthritis (a condition associated with an increased frequency of DR-4).Keywords
This publication has 4 references indexed in Scilit:
- Apolipoprotein E genotyping in Alzheimer's diseaseThe Lancet, 1996
- THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASEAnnual Review of Medicine, 1996
- Continuing Medical EducationHospital Practice, 1995
- Neuroimmunology of Alzheimer's disease: A conference reportNeurobiology of Aging, 1992